ClinicalTrials.Veeva

Menu

Community-Centered eHealth Smoking Cessation Intervention(CCeSCI)

D

Duke Kunshan University

Status

Completed

Conditions

Lifestyle, Healthy
Smoking Cessation

Treatments

Other: Community-Centered eHealth Smoking Cessation Intervention (CCeSCI)
Other: Traditional "smoking is harmful" education

Study type

Interventional

Funder types

Other

Identifiers

NCT05508672
22KDKUF016

Details and patient eligibility

About

Recent findings regarding why Chinese male smokers are reluctant to quit have offered insight for a possible new solution. Consistent with the Cognitive Dissonance Theory, "smoking rationalization beliefs" are a set of beliefs by smokers to rationalize their smoking behavior and avoid quitting. These beliefs have been well studied by global researchers, and a "smoking rationalization beliefs" scale was recently developed and validated for Chinese male smokers. The six dimensions of these beliefs are: smoking functional beliefs, risk generalization beliefs, social acceptability beliefs, safe smoking beliefs, self-exempting beliefs, and quitting is harmful beliefs. Studies on smoking rationalization in China have primarily been observational. Investigators propose to develop a Community-Centered eHealth Smoking Cessation Intervention (CCeSCI). The trinity of CCeSCI are the triangular unity of "smoking rationalization beliefs" framework, the non-physician community workers, and the eHealth technologies. The latter two were previously proven effective in interventional studies (including three conducted by the PI) but not yet widely used in smoking cessation. With the adoption of smoking rationalization beliefs framework aiming to address the cognitive causes of phycological addition to smoking and supported by the community-based behavioral interventions and the use of eHealth, CCeSCI is designed to overcome previous challenges with the principles of people-centeredness, convenience, and personalization.

Full description

Investigators will firstly evaluate the feasibility of CCeSCI. Once CCeSCI is ready to deploy, investigators will recruit 60 smokers (male, 25-64 years old) in two communities in Qingpu to conduct a pilot non-blinded randomized controlled trial. They will be randomized in a 1:1 ratio into either the intervention group to receive CCeSCI or the control group to receive the traditional "smoking is harmful" education video. Investigators will also use qualitative research methods (one on one interviews) to conduct process evaluations at 4th, 8th, and 12th weeks according to the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework. At the end of the 12th week after the participants joined the RCT, saliva samples will be collected by community workers and quitting outcomes will be biochemically verified by a third party lab.

Enrollment

60 patients

Sex

Male

Ages

25 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Male, current cigarette smokers who are willing to quit
  2. Citizens who currently reside in Qingpu District, Shanghai, China
  3. Age 25-64
  4. Smoking index greater than or equal to 100 (smoking index = average number of cigarettes smoked per day × years of smoking)
  5. Able to understand mandarin Chinese
  6. Willing to provide informed consent to participate in the study

Exclusion criteria

  1. Ever or currently on pharmacologic treatments, including various forms of NRT formulations such as gum, transdermal patch, nasal spray, oral inhaler, lozenge, Bupropion, Varenicline and newly emerged precision medicine
  2. Currently participating in other individual-based cessation program(s), such as psychological counseling, behavioral therapy etc.
  3. Currently under treatment of life-threatening medical conditions or critically ill
  4. Unable to make commitment of a consecutive 4-hour video viewing
  5. Plan to move out of the community in the next 3 month

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Community-Centered eHealth Smoking Cessation Intervention (CCeSCI) group
Experimental group
Description:
The intervention group will receive Community-Centered eHealth Smoking Cessation Intervention(CCeSCI).
Treatment:
Other: Community-Centered eHealth Smoking Cessation Intervention (CCeSCI)
Traditional "smoking is harmful" education group
Active Comparator group
Description:
The control group to receive the traditional "smoking is harmful" education.
Treatment:
Other: Traditional "smoking is harmful" education

Trial contacts and locations

1

Loading...

Central trial contact

Lijing Yan, PhD; Ray Wang, BEc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems